APOGEM CAPITAL LLC ALDX Holdings History

Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$38,498.72
% of Total Estimate Gain
3.64%

APOGEM CAPITAL LLC's Aldeyra Therapeutics Inc Holding Summary

As of 2022-12-31, APOGEM CAPITAL LLC held - shares of Aldeyra Therapeutics Inc(ALDX), totaling N/A. This investment constitutes 0% of their stock portfolio, and APOGEM CAPITAL LLC now holds 0% of the outstanding Aldeyra Therapeutics Inc(ALDX) stock.

The initial trade took place in 2020Q4. And since then APOGEM CAPITAL LLC has made 5 purchases of ALDX, at an average price of $6.27, for a total of 168,858.00 shares. In addition, there have been 3 sales at an average price of $6.50 for 168,858.00 shares. Based on historical transaction data and ALDX's current price of $3.05, APOGEM CAPITAL LLC's estimated gain on his ALDX holdings is $38,498.72, reflecting a 3.64% gain to date.

APOGEM CAPITAL LLC ALDX ($3.05) Holding Chart

APOGEM CAPITAL LLC ALDX ($3.05) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1